Busulfan suppliers
Busulfan
- CAS:
- 55-98-1
- MF:
- C6H14O6S2
- MW:
- 246.3
Suppliers by country/region
Company Type
Properties
- Melting point:
- 114-117 °C(lit.)
- Boiling point:
- 359.3°C (rough estimate)
- Density
- 1.305 (estimate)
- refractive index
- 1.5630 (estimate)
- Flash point:
- 9℃
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- Very slightly soluble in water, freely soluble in acetone and in acetonitrile, very slightly soluble in ethanol (96 per cent).
- form
- Crystalline Powder
- color
- Pale Brown
- Water Solubility
- Decomposes
- Merck
- 14,1505
- BRN
- 1791786
- Stability:
- Moisture Sensitive
Safety Information
- Symbol(GHS)
GHS06,GHS08
- Signal word
- Danger
- Hazard statements
- H301-H340-H350-H360FD
- Precautionary statements
- P202-P264-P270-P280-P301+P310-P405
- Hazard Codes
- T+,T,F
- Risk Statements
- 45-26/27/28-63-46-36/37/38-23/24/25-39/23/24/25-11
- Safety Statements
- 53-36/37/39-45-28A-36/37-16-7
- RIDADR
- UN 2811 6.1/PG 1
- WGK Germany
- 3
- RTECS
- EK1750000
- HazardClass
- 6.1(b)
- PackingGroup
- III
- HS Code
- 29053990
- Toxicity
- LD50 i.v. in rats: 1.8 mg/kg (Scherf)
Use
Busulfan is a cytotoxic alkylating chemotherapeutic agent that is extensively used as preparative conditioning regimen prior to allogeneic HSCT for hematologic malignancies. Busulfan has been widely used in the treatment of CML and other hematologic malignancies and myelodysplastic disorders. The principal effect of busulfan is myelosuppression and myeloablation when used at the recommended dosage. Currently, busulfan is indicated for use in combination with cyclophosphamide to destroy cancer cells and make room for new bone marrow to grow prior to a bone marrow or peripheral blood progenitor cell replacement procedure. As a component of a conditioning regimen for HSCT, busulfan also suppresses the immune system so that the patient does not reject the new bone marrow.
320 supplier list of "Busulfan"